Reimportation of Medications (Resolution No. 99-5-03)

Topics: Resolutions

Resolution No. 99-5-03
Title: Reimportation of Medications

Whereas, an alarming and increasing number of consumers are purchasing medications from sources outside of the US to meet their prescription needs and obtain these medications at lower prices than available in the US; and

Whereas, this practice is in violation of the law and eliminates the physician, pharmacist, patient relationship and the opportunity for meaningful pharmaceutical care thus detrimentally affecting the protection afforded patients; and

Whereas, NABP has expressed its great concern of the detrimental effect of this practice on the public health to the (1) US Department of Health & Human Services (HHS), (ii) the federal Food and Drug Administration (FDA), (iii) the National Association of Pharmacy Regulatory Authorities (NAPRA) (Canada), (iv) in testimony before the United States Congress, and (v) through the issuance of a Position Paper (March, 2003); and

Whereas, a cooperative effort between the state boards of pharmacy, provincial authorities of Canada, the Food and Drug Administration (FDA), and pharmaceutical manufacturers is the best means to address this public health concern;

THEREFORE BE IT RESOLVED that NABP maintain its efforts to eliminate this dangerous and unlawful practice, continue to support the efforts of the state boards that are taking action against the pharmacies and facilitators involved in these activities, and encourage the FDA to continue its efforts to enforce the existing laws on importation and reimportation of drugs; and

BE IT FURTHER RESOLVED that NABP express its concern over the effect that pricing policies for pharmaceuticals are having on the public health; and

BE IT FURTHER RESOLVED that NABP continue to work with NAPRA and other entities to address this issue and communicate with Canadian provincial authorities in order to obtain enforcement proceedings in Canada to eliminate this practice.

(Resolution passed at NABP’s 99th Annual Meeting, Philadelphia, PA)